BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31135834)

  • 1. Cervical Cancer Screening: More Choices in 2019.
    Sawaya GF; Smith-McCune K; Kuppermann M
    JAMA; 2019 May; 321(20):2018-2019. PubMed ID: 31135834
    [No Abstract]   [Full Text] [Related]  

  • 2. The renewal of the National Cervical Screening Program.
    Carter J
    Med J Aust; 2016 Oct; 205(8):357-358. PubMed ID: 27736622
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for Cervical Cancer.
    Ngo-Metzger Q; Adsul P
    Am Fam Physician; 2019 Feb; 99(4):253-254. PubMed ID: 30763054
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
    Kim JJ; Burger EA; Sy S; Campos NG
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New guidelines on cervical cancer screening: more than just the end of annual Pap testing.
    Massad LS
    J Low Genit Tract Dis; 2012 Jul; 16(3):172-4. PubMed ID: 22820979
    [No Abstract]   [Full Text] [Related]  

  • 7. A decade has passed...the Pap smear and cervical cancer.
    Linder J
    Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
    [No Abstract]   [Full Text] [Related]  

  • 8. Papanicolaou testing: when does more become less?
    Sawaya GF
    Am J Med; 2005 Feb; 118(2):159-60. PubMed ID: 15694901
    [No Abstract]   [Full Text] [Related]  

  • 9. Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management.
    Stumbar SE; Stevens M; Feld Z
    Prim Care; 2019 Mar; 46(1):117-134. PubMed ID: 30704652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
    Fontaine PL; Saslow D; King VJ
    Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
    [No Abstract]   [Full Text] [Related]  

  • 11. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
    Sawaya GF
    Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
    [No Abstract]   [Full Text] [Related]  

  • 12. Gynecologists and human papillomavirus DNA testing: exploring knowledge, attitudes, and practice in Italy.
    Caglioti C; Pileggi C; Nobile CG; Pavia M
    Eur J Cancer Prev; 2017 May; 26(3):249-256. PubMed ID: 27879494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of colposcopy in Population Program of Cervical Cancer Early Detection].
    Wojciech R
    Ginekol Pol; 2007 Sep; 78(9):719-22. PubMed ID: 18159827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Annual Gynecologic Examination Updated for the 21st Century.
    Cappiello J; Levi A
    Nurs Womens Health; 2016; 20(3):315-9. PubMed ID: 27287359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the Validity and Reproducibility of the Pap Smear in Mexico: Necessity of a Paradigm Shift.
    Yunes-Díaz E; Ruiz PA; Lazcano-Ponce E
    Arch Med Res; 2015 May; 46(4):310-6. PubMed ID: 26054968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes on the horizon for cervical cancer screening.
    Isidean SD; Shinder GA
    Prev Med; 2017 May; 98():1-2. PubMed ID: 28034732
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for cervical cancer. Current terminology, classification, and technique.
    Fowler J
    Postgrad Med; 1993 Feb; 93(2):57-64, 70. PubMed ID: 8381956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Controversies in Cervical Cancer Screening.
    Bus-Kwofie A; Chan C; Kahn R; Holcomb K
    Clin Obstet Gynecol; 2019 Dec; 62(4):644-655. PubMed ID: 31305485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.